Financial results for the period ended Jun 30, 2026
As filed · Suven Life Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
What happened
FactSuven Life Sciences Limited's Board of Directors approved the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026, during a meeting held on August 6, 2026. The review reports from the Statutory Auditors and a news release were also enclosed with the filing. The meeting commenced at 11:30 AM and concluded at 12:30 PM (IST).
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Working Capital
RevisedNumber of days of accounts Payables 40
Number of days of accounts Payables 48*
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- Continue to conduct health and wellness programs aimed at improving the physical and mental well-being of our (management committed by FY27)
- Implement learning/training programs to ensure that 100% of our employees have access to professional developm (management committed by FY27)
Evidence
- Suven Life Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.(opens the original filing in a new tab)
- Earlier statement · FY26
- Latest statement · FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%